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A B S T R A C T
Introduction: Restrictive spirometry pattern is an under-recognised disorder with a poor morbidity and mortality
prognosis. We compared physical activity levels between adults with a restrictive spirometry pattern and with
normal spirometry.
Methods: Restrictive spirometry pattern was defined as a having post-bronchodilator FEV1/FVC≥Lower Limit
of Normal and a FVC<80% predicted in two population-based studies (ECRHS-III and SAPALDIA3). Physical
activity was measured using the International Physical Activity Questionnaire. The odds of having low physical
activity (< 1st study-specific tertile) was evaluated using adjusted logistic regression models.
Results: Subjects with a restrictive spirometry pattern (n=280/4721 in ECRHS, n= 143/3570 in SAPALDIA)
reported lower levels of physical activity than those with normal spirometry (median of 1770 vs 2253 MET·min/
week in ECRHS, and 3519 vs 3945 MET·min/week in SAPALDIA). Subjects with a restrictive spirometry pattern
were more likely to report low physical activity (meta-analysis odds ratio: 1.41 [95%CI 1.07–1.86]) than those
with a normal spirometry. Obesity, respiratory symptoms, co-morbidities and previous physical activity levels
did not fully explain this finding.
Conclusion: Adults with a restrictive spirometry pattern were more likely to report low levels of physical activity
than those with normal spirometry. These results highlight the need to identify and act on this understudied but
prevalent condition.
1. Introduction
Restrictive spirometry pattern is an under-recognised disorder with a
poor morbidity and mortality prognosis [1–3]. It is characterised by re-
duced levels of both forced expiratory volume in 1 second (FEV1) and
forced vital capacity (FVC), while the FEV1/FVC ratio remains within
normal ranges. This heterogeneous disorder is composed partly of sub-
jects who exhibit reduced total lung capacity (TLC) (truly restrictive
disease) but also includes subjects with normal TLC [4]. Its causes are
diverse and include lung fibrosis, systemic inflammation, obesity and
psychological health, among others [1,5]. The prevalence of restrictive
spirometry pattern in adults is estimated to be between 5 and 10% [6,7],
nearly as high as the prevalence of chronic obstructive pulmonary dis-
ease (COPD). In contrast to COPD, which is very well known and studied,
restrictive spirometry pattern has only recently received any attention
and there is no clear recommendation for its management [8].
Impaired quality of life [9], important functional limitations [10]
and a higher risk of suffering cardiovascular events [11–13] have all
been associated with restrictive spirometry pattern. Furthermore, an
association between restrictive spirometry pattern and mortality has
been consistently found across studies in different settings and using
different definitions [1–3,14,15]. However, the underlying causes of
these observed associations remain unknown.
We here hypothesize that reduced levels of physical activity in subjects
with a restrictive spirometry pattern could be one potential pathway linking
this condition to higher mortality, in particular from cardiovascular disease
[3]. Indeed, low physical activity levels have been consistently associated
with high mortality in general population samples from diverse geographical
origins [16,17]. In some chronic respiratory diseases, low physical activity
levels have been related to a worse prognosis in terms of exacerbations and
mortality [18]. Therefore, studying physical activity levels in subjects with a
restrictive spirometry pattern is timely as it may identify potentially mod-
ifiable factors that could affect the prognosis of this disorder.
The present study aimed to 1) describe current levels of physical
activity in adults with a restrictive spirometry pattern, and 2) compare
them to the physical activity levels found in adults with normal spiro-
metry, using data from two population-based adult European studies.
2. Material and methods
2.1. Study design
This cross-sectional study used data from two prospective adult
cohorts participating in the ALEC project (www.alecstudy.org): the
European Community Respiratory Health Survey (ECRHS) [19] and the
Swiss study on Air Pollution and Lung Disease in adults (SAPALDIA)
[20]. Both studies collected information on lung function and physical
activity using similar protocols and highly comparable questionnaires.
Details of both cohorts have been described elsewhere [19,20].
Briefly, ECRHS is a multi-centre cohort involving 46 centres in 25
countries, mostly across Europe (ECRHS I). Participants between 20 and
44 years of age were randomly selected from the population and com-
plemented with a sample of subjects with asthma-related symptoms, the
latter of which was excluded in the present analysis. Two follow-ups took
place approximately 10 years (ECRHS II) and 20 years (ECRHS III) after
the initial recruitment, which was in 1990–92. In SAPALDIA, random
samples of the population (between 18 and 60 years of age) were re-
cruited in 1991 in eight communities in Switzerland. Participants were
followed-up in 2001 and 2011 (SAPALDIA 1, 2 and 3).
The current analysis uses data collected at the last follow-up of both
ECRHS and SAPALDIA, where physical activity was measured using an
internationally validated questionnaire. We excluded the symptomatic
sample (in ECRHS) and subjects with obstructive spirometry (in both
studies). Written informed consent was obtained from all participants
and the studies were approved in each participating centre by the ap-
propriate institutional ethics committees.
2.2. Lung function measurement
Lung function was measured using NDD Easyone spirometers in
both studies. In ECRHS, measurements reproducible to 150mL from at
least two of a maximum of five correct manoeuvres were included,
following American Thoracic Society recommendations [21]. In SAP-
ALDIA, measurements reproducible within 5% and with less than
100ml difference were included. We derived the percent value pre-
dicted for FVC and the Lower-Limit of Normal (LLN) for the FEV1/FVC
ratio using study-specific equations [9,22]. A restrictive spirometry
pattern was defined as having a post-bronchodilator FEV1/FVC≥ LLN
and a FVC<80% predicted [7].
Subjects with neither a restrictive nor an obstructive (post-bronch-
odilation FEV1/FVC < LLN) pattern were defined as having normal
spirometry.
2.3. Outcome: physical activity
Physical activity was assessed using two measures. First, we used
the International Physical Activity Questionnaire (IPAQ) which has
been validated in multiple international settings and population groups
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[23] and has two versions: the IPAQ-SF short form (used in ECRHS) and
the IPAQ-LF long form (used in SAPALDIA). Both IPAQ versions collect
information on the time spent walking and doing physical activity at
different intensities in the previous week. From these questions, we
obtained continuous measures of Metabolic Equivalents of Task
(MET)·min per week, using the official IPAQ scoring protocol (www.
ipaq.ki.se). The MET is an intensity unit of physical activity determined
as the ratio between the metabolic rate during a given activity over the
resting metabolic rate. Physical activity volume (in MET·min/week) in
walking, moderate and vigorous physical activity was calculated as the
multiplication of the time spent doing each activity during a week and
the intensity of this activity. Total physical activity was calculated as
the sum of all components. Because the IPAQ-LF includes more detailed
questions than the IPAQ-SF, all physical activity estimates from the
IPAQ-LF (used in SAPALDIA) are expected to be higher than those from
the IPAQ-SF (used in ECRHS) [23]. Thus, we defined study-specific
tertiles of walking, moderate, vigorous and total physical activity.
Subjects in the lowest tertile were classified as having “low physical
activity”.
Second, because the physical activity levels derived from the two
different IPAQ versions cannot be directly compared, a second definition
was used, which is not validated but is homogeneous across the two
studies. Using identical questions, both the ECRHS and SAPALDIA col-
lected information on how often (frequency) and for how many hours per
week (duration) participants usually exercised so much that they got out
of breath or sweaty. Individuals were categorised as active if they ex-
ercised with a frequency of 2–3 times a week or more and with a
duration of about 1 h a week or more, as previously published [24,25].
Participants were defined as having “low physical activity” otherwise.
2.4. Body weight and composition
Body Mass Index (BMI) was calculated from measured height and
weight, and categorised into normal, overweight and obese, according
Fig. 1. Study flow-chart.
Abbreviations
BMI Body mass index
ECRHS European Community Respiratory Health Survey
FEV1 Forced expiratory volume in one second
FVC Forced vital capacity
IPAQ-LF International Physical Activity Questionnaire Long Form
IPAQ-SF International Physical Activity Questionnaire Short Form
LLN Lower limit of normal
MET Metabolic Equivalent of Task
OR Odds ratio
SAPALDIA Swiss study on Air Pollution And Lung Disease In Adults
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to the World Health Organization's classification [26]. In ECRHS, fat
mass and fat free mass were derived from measurements of resistance
and reactance provided by bioimpedance using the equations devel-
oped by Sun et al. [27].
2.5. Other relevant covariates
Information on the characteristics (age, sex, education, smoking
status and passive smoking), current (within the last 12 months) re-
spiratory symptoms (asthma attack, wheezing, woken with tight chest,
woken by attack of shortness of breath, woken by attack of coughing
and avoiding exercise because of breathing problems), chronic re-
spiratory symptoms (ever asthma, chronic bronchitis and chronic
cough) and diagnosed chronic conditions (diabetes, heart disease,
depression, stroke and hypertension) of the participants was collected
using questionnaires. Previous levels of physical activity (frequency and
duration of vigorous physical activity and active status) were also
available from surveys conducted 10 years before.
2.6. Statistical analysis
We used medians and 25th-75th percentiles as well as absolute and
relative frequencies to describe the physical activity levels among
adults with a restrictive pattern and those with normal spirometry.
To compare the physical activity levels between these groups, we
estimated the association between spirometry pattern (restrictive pat-
tern vs normal) and physical activity (low vs not low) using logistic
regression. We assessed the odds of having low physical activity
Table 1
Subject characteristics according to study and spirometry patterns.
ECRHS SAPALDIA
Normal spirometry Restrictive spirometry pattern p-value Normal spirometry Restrictive spirometry pattern p-value
n (%)/m (sd) n (%)/m (sd) n (%)/m (sd) n (%)/m (sd)
Sex Female 2152 (53%) 150 (54%) 0.769 1522 (49%) 81 (57%) 0.065
Age (years) 53.8 (7.0) 53.9 (7.1) 0.876 58.4 (10.9) 60.8 (11.2) 0.011
BMI < 0.001 <0.001
Underweight (< 18.5 kg/m2) 27 (0.7%) 2 (0.7%) 34 (1.1%) 3 (2.1%)
Normal (18.5–24.9 kg/m2) 1548 (38.0%) 79 (28.6%) 1311 (42.0%) 41 (28.7%)
Overweight (25.0–29.9 kg/m2) 1668 (41.0%) 81 (29.3%) 1230 (39.4%) 54 (37.8%)
Obese (≥30 kg/m2) 826 (20.3%) 114 (41.3%) 547 (17.5%) 45 (31.5%)
Education 0.066 0.001
Low 302 (7.6%) 26 (9.6%) 156 (5.0%) 6 (4.2%)
Medium 1308 (33.1%) 104 (38.2%) 1995 (63.9%) 113 (79.0%)
High 2346 (59.3%) 142 (52.2%) 970 (31.1%) 24 (16.8%)
Smoking status 0.425 0.805
Never smoker 1733 (42.4%) 115 (41.1%) 1402 (44.9%) 66 (46.2%)
Exsmoker 1636 (40.0%) 105 (37.5%) 1237 (39.6%) 53 (37.1%)
Current smoker 696 (17.0%) 58 (20.7%) 482 (15.4%) 24 (16.8%)
Smoking (Pack-years) 9.6 (16.9) 12.5 (17.9) 0.007 10.7 (17.7) 15.5 (23.6) 0.002
Total energy intake (Kcal/day) 2943 (1029) 2986 (1223) 0.577 2160 (937) 2079 (891) 0.444
Exposed to passive smoking (last 12mo) 677 (16.7%) 72 (25.9%) < 0.001 360 (11.5%) 24 (16.8%) 0.057
Ever exposed to vapour, gas, dust or fumesa 616 (22.7%) 29 (16.5%) 0.055 524 (17.2%) 25 (17.9%) 0.837
Low physical activity 10-years before 1962 (61.4%) 145 (68.1%) 0.052 1907 (67.2%) 97 (77.0%) 0.021
Respiratory symptoms
Any asthma attacks (last 12mo) 139 (3.4%) 23 (8.3%) < 0.001 75 (2.4%) 5 (3.5%) 0.408
Wheezing/whistling (last 12mo) 681 (16.7%) 104 (37.1%) < 0.001 309 (10.0%) 29 (20.4%) <0.001
Woken with tight chest (last 12mo) 421 (10.4%) 43 (15.4%) 0.009 316 (10.2%) 17 (11.9%) 0.525
Woken by attack of SOB (last 12mo) 209 (5.2%) 33 (12.0%) < 0.001 106 (3.4%) 10 (7.0%) 0.023
Woken by attack of coughing (last 12mo) 1138 (27.9%) 102 (36.7%) 0.002 591 (19.2%) 31 (21.7%) 0.460
Avoid vigorous exerciseb (last 12mo) 115 (3.1%) 32 (12.1%) < 0.001 44 (1.4%) 5 (3.6%) 0.043
Chronic coughc 258 (6.8%) 25 (9.7%) 0.069 137 (4.4%) 12 (8.4%) 0.025
Dyspnead 119 (2.9%) 25 (8.9%) < 0.001 NA NA
Lung function
Post-bronchodilator FEV1 (L) 4.2 (0.9) 3.0 (0.7) < 0.001 3.1 (0.8) 2.2 (0.6) < 0.001
Post-bronchodilator FVC (L) 3.3 (0.7) 2.4 (0.6) < 0.001 4.2 (1.0) 3.0 (0.8) < 0.001
FEV1/FVC 0.78 (0.05) 0.80 (0.05) < 0.001 0.74 (0.05) 0.74 (0.07) 0.614
Ever had been diagnosed with the following conditions:
Asthma 435 (10.7%) 48 (17.1%) 0.001 330 (10.6%) 24 (16.8%) 0.019
Chronic bronchitise 192 (5.1%) 20 (7.5%) 0.090 74 (2.4%) 14 (9.9%) <0.001
Other lung diseasef 290 (7.8%) 25 (9.4%) 0.328 NA NA
Heart disease 93 (2.5%) 19 (7.1%) < 0.001 NA NA
Stroke 33 (0.8%) 6 (2.2%) 0.022 43 (1.4%) 2 (1.4%) 0.973
Hypertension 858 (21.1%) 107 (38.2%) < 0.001 841 (27%) 62 (43.7%) <0.001
Diabetes 163 (4.4%) 38 (14.3%) < 0.001 176 (5.6%) 20 (14.1%) <0.001
Cancer 201 (5.0%) 20 (7.1%) 0.108 235 (7.9%) 9 (6.6%) 0.575
Rheumatoid arthritis 130 (3.2%) 14 (5.0%) 0.109 140 (4.5%) 6 (4.3%) 0.887
Depression 600 (14.8%) 61 (21.9%) 0.002 NA NA
m: mean sd: standard deviation. SOB: shortness of breath. mo: month. NA: Not Available in this study. P-values from chi2 test (categorical) and anova (continous).
a Occupational exposure to vapour, gas, dust and fumes.
b Avoid taking vigorous exercise because of breathing problems.
c Cough during the day or at night on most days for at least 3 months each year and at least 2 years.
d Dyspnea: Dyspnea grade 2 (MMRC Dyspnea Scale).
e Doctor-diagnosed chronic bronchitis.
f Excluding asthma, chronic bronchitis, COPD and emphysema.
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(defined as (1) being in the lowest study-specific tertile of MET·min/
week of total physical activity, and (2) being low physically active
according to frequency and duration questions) in subjects with a re-
strictive spirometry pattern compared to those with normal spirometry
(reference group). Centre was included as a random effect in order to
account for the correlation among individuals within the same area.
Models were adjusted for potential confounders if these were sig-
nificantly associated with the exposure (i.e. spirometry pattern). Tested
confounders were: BMI, education, smoking status, pack-years, passive
exposure to smoking, reported physical activity at previous survey and
each of the available chronic conditions. The linearity of the association
for continuous variables (BMI, age and pack-years) was examined using
generalised additive models (GAM). Pooling of data from the two stu-
dies was not warranted due to some differences in variable definitions.
Therefore, study-specific estimates were meta-analysed to obtain a
combined estimate. We stratified analyses by BMI, smoking status and
gender to assess possible effect modification.
Several sensitivity analyses were performed: (1) GLI equations [28]
were used rather than study-specific equations to define spirometry
patterns; (2) a cut-off of< 2000 MET·min/week was used to define low
physical activity levels in both studies instead of the study-specific
lowest tertiles; (3) asthmatics were excluded; (4) subjects with re-
spiratory symptoms were excluded; (5) models were adjusted for per-
cent fat-mass (only available in the ECRHS) to rule out potential re-
sidual confounding by obesity; (6) pre-bronchodilator spirometry data
were used to define spirometry patterns, thus increasing the number of
participants with a restrictive spirometry pattern; and (7) loss of par-
ticipants from ECRHS I to ECRHS III was corrected for using inverse
probability weighting, with the probability weights estimated from a
logistic regression having as the outcome “participation to ECRHS III”
and as the exposures: age, sex, asthma, smoking status, education, BMI,
attack of shortness of breath in the last 12 months, breathing difficulties
and dyspnoea, all assessed at ECRHS 1.
3. Results
3.1. Sample characteristics
A total of 4721 ECRHS participants and 3570 SAPALDIA partici-
pants had lung function and physical activity data available (Fig. 1).
In both studies, the participants included in the analysis were
younger, leaner, more highly educated and less likely to smoke than the
initial sample. There were 280 (5.9%) and 143 (4.0%) participants with
a restrictive spirometry pattern and 355 (7.5%) and 305 (8.5%) parti-
cipants with an obstructive spirometry pattern in ECRHS and SAPAL-
DIA, respectively. In both studies, subjects with a restrictive spirometry
pattern were more likely to be obese, have a lower level of education,
have current respiratory symptoms (wheezing, attack of cough, tight
chest) and report a diagnosis of hypertension or diabetes, compared to
subjects with normal spirometry. There were no differences in terms of
smoking status (Table 1).
3.2. Overall physical activity levels and by spirometry pattern
The median total physical activity level was 2146
(P25eP75= 1023–4158) MET·min/week in ECRHS (from the IPAQ-SF)
and 3908 (P25eP75= 2041–7344) MET·min/week in SAPALDIA (from
the IPAQ-LF). The main source of total physical activity was ‘walking’
in ECRHS and ‘moderate activity’ in SAPALDIA. The proportion of
subjects who exercised less than 2 times a week and with a duration of
less than 1 h ranged between 55% in the normal spirometry group from
ECRHS to 80% in the restrictive spirometry pattern group from SAP-
ALDIA (Table 2).
In ECRHS, subjects with a restrictive spirometry pattern reported
significantly lower levels of physical activity than subjects with normal
spirometry. In SAPALDIA, these differences were only apparent for total
physical activity. The proportion of subjects classified as having low
physical activity was higher among participants with a restrictive
spirometry pattern compared to those with normal spirometry, using
both methods to define low physical activity.
Table 2
Distribution of the physical activity variables by study and spirometry patterns.
ECRHS SAPALDIA
Normal spirometry Restrictive spirometry
pattern
p-value Normal spirometry Restrictive spirometry
pattern
p-value
Physical Activity measured by IPAQ
Walking (MET·min/weeka), median (P25eP75) 792 (346.5–1584) 693 (256–1386) 0.025 1089 (396–2376) 1188 (198–2310) 0.434
Moderate activityb (MET·min/weeka), median (P25eP75) 360 (0–960) 240 (0–720) 0.068 1740 (630–3780) 1440 (480–3563) 0.157
Vigorous activity (MET·min/weeka), median (P25eP75) 240 (0–1440) 0 (0–960) 0.004 0 (0–1440) 160 (0–960) 0.498
Total physical activity (MET·min/weeka), median
(P25eP75)
2253 (1116–4158) 1770 (693–3205) < 0.001 3945 (2070–7494) 3519 (1584–6732) 0.096
Low physical activity (< 1st tertile of total physical
activityc), n (%)
962 (32.8%) 94 (46.8%) < 0.001 655 (32.1%) 32 (37.6%) 0.280
Physical activity measured by questions on frequency and duration of leisure-time vigorous physical activity
Frequency of exercise, n (%) 0.002 0.476
Never/<1month 1465 (36.0%) 130 (46.8%) 1376 (44.7%) 72 (50.7%)
1/week 694 (17.1%) 44 (15.8%) 686 (22.3%) 31 (21.8%)
2–3 times/week 1243 (30.6%) 75 (26.9%) 756 (24.6%) 28 (19.7%)
4 + times/week 667 (16.4%) 29 (10.4%) 261 (8.5%) 11 (7.7%)
Duration of exercise, n (%) < 0.001 0.137
<1 h 1512 (37.8%) 131 (47.6%) 1519 (49.6%) 83 (58.0%)
1–3 h 1652 (41.3%) 111 (40.4%) 1319 (43.0%) 52 (36.4%)
4 h or more 832 (20.8%) 33 (12.0%) 226 (7.4%) 8 (5.6%)
Low physical activity (< 2 times or <1 h/week), n (%) 2210 (55.3%) 179 (65.3%) < 0.001 2194 (72.0%) 113 (79.6%) 0.047
MET: metabolic equivalent of task. IPAQ: International Physical Activity Questionnaire. P-values from Kruskal-Wallis rank test (continous) and chi2 (categorical).
a As a reference, WHO recommendation of 75min/week of vigorous activity is equivalent to 1200 MET·min/week, and 150min/week of moderate activity are
equivalent to 600 MET·min/week.
b Not including walking.
c < 1390 MET·min/week in ECRHS;< 2550 MET·min/week SAPALDIA.
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3.3. Associations between restrictive spirometry pattern and low physical
activity
Subjects with a restrictive spirometry pattern had higher odds of
reporting low physical activity than those with normal spirometry in
the study-specific analyses and the meta-analysis, for both definitions of
low physical activity (Fig. 2).
When the models were stratified by BMI, this association was
strongest among overweight (but not obese) individuals, although the
interaction term was not significant (Fig. S1). There was no consistent
evidence for effect modification by gender or smoking status (Fig. S1),
but due to the small number of subjects in each subgroup of these
stratified analyses, the confidence intervals are large.
No differences in the estimates were observed in any of the sensi-
tivity analyses tested (Fig. S2), except in a single case when using the
GLI equations in SAPALDIA. However, the confidence intervals for this
association were wide as the number of subjects with a restrictive
spirometry pattern was much lower when defined using the GLI equa-
tions (n= 53) compared to when using the study-specific lung re-
ference equations (n=143). Nevertheless, the overall combined esti-
mate remained significantly positive.
4. Discussion
Using data from two large European multi-centre population based
studies, we found that physical activity levels were significantly lower
among subjects with a restrictive spirometry pattern compared to those
with normal spirometry. This paper is the first to explore physical ac-
tivity levels in those with a restrictive spirometry pattern in a popula-
tion setting, even though five percent of the population has this con-
dition and it is known to be related to morbidity and mortality. The
association observed was independent of age, smoking, co-morbidities,
total body mass, fat mass and the presence of respiratory symptoms.
4.1. Main findings
Physical activity levels in subjects with a restrictive spirometry
pattern were relatively low. The median total physical activity was
1770 MET·min/week in ECRHS, using the IPAQ-SF, and 3519 MET·min/
week in SAPALDIA, using the IPAQ-LF. These values are lower than the
corresponding medians of 2514 and 3699 MET·min/week observed in
the international validation in adults of the IPAQ-SF and IPAQ-LF, re-
spectively [23]. It is worth noting that the participants in our analysis
with a restrictive spirometry pattern barely performed any vigorous
physical activity, with median values of 0 MET·min/week in ECRHS and
160 MET·min/week in SAPALDIA. As reference values, the World
Health Organization recommends 75min/week of vigorous activity and
150min/week of moderate activity, which are equivalent to 1200
MET·min/week and 600 MET·min/week, respectively [29]. Worryingly,
because both of the IPAQ versions have been reported to overestimate
physical activity levels [23,30,31], it is likely that the true physical
activity levels in our study population are lower than reported here.
Finally, the lower IPAQ-derived physical activity levels observed in
ECRHS compared to SAPALDIA are likely due to the different ques-
tionnaire versions used. Indeed, when using the questions about fre-
quency and duration of physical activity, which are identical in both
cohorts, the SAPALDIA participants (who are slightly older) reported
lower physical activity levels.
Our finding that physical activity levels are lower among those with
a restrictive spirometry pattern agrees with a previous report which was
based on a small number (37) of cases. This previous work found a
positive association between having a restrictive spirometry pattern
and physical inactivity measured by accelerometer [32]. Cross-sec-
tional studies have also identified that other constructs related to
Fig. 2. Odds ratios (OR) and 95% con-
fidence interval for low physical activity
in subjects with a restrictive spirometry
pattern compared to those with a
normal spirometry pattern (reference
group), in ECRHS (dashed line), SAPA-
LDIA (dotted line) and the meta-analysis
(solid line).
Lowest study-specific tertile in
ECRHS:< 1390; in SAPALDIA:< 2550
MET·min/week. OR adjusted for age,
sex, ever diagnosed with diabetes, being
physically active in previous follow-up
and BMI (all models), and, when ap-
propriate, smoking, education, diag-
nosis of depression, hypertension,
stroke or heart disease (see full model in
Supplemental Table S1).
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physical activity, such as exercise performance and the physical com-
ponent of quality of life, are reduced in subjects with a restrictive
spirometry pattern [9,14], which supports the plausibility of our re-
sults.
Our study goes beyond previous work by demonstrating that these
differences in physical activity levels are unlikely to be due to con-
founding by age, smoking, obesity or other health conditions.
There are several potential explanations for the associations we
observed. First, subjects with a restrictive spirometry pattern have a
high prevalence of chronic respiratory symptoms [1], which may lead
them to reduce their physical activity levels in order to avoid symp-
toms. However, our results remained after excluding subjects with re-
spiratory symptoms. Second, confounding by overweight and obesity is
possible as both of these conditions are related to restrictive spirometry
pattern and low levels of physical activity. However, the results did not
change when we adjusted the models by either BMI or percent of fat-
mass. Third, subjects with a restrictive spirometry pattern might be-
come breathless at lower workloads compared to subjects with normal
spirometry, and may therefore reduce their physical activity to avoid
breathlessness. Finally, lack of physical activity may lead to higher risk
of restrictive spirometry pattern, rather than restrictive spirometry
pattern leading to lower physical activity. Doing regular physical ac-
tivity has been found to be associated with higher lung function levels
[25,33], which could lower the risk of having a restrictive spirometry
pattern. Although we adjusted the models for physical activity levels
ten years prior, the cross-sectional design of our analysis prevents us
from establishing the direction of the true causal pathway. Identifying
whether low physical activity is a risk factor for the onset of restrictive
spirometry pattern is an important question which, needs to be ad-
dressed in future longitudinal studies.
We did not observe convincing evidence for effect modification by
smoking or sex. However, the stratified analyses had low statistical
power which makes it difficult to draw firm conclusions. Future studies
with more subjects in each group are needed. We observed a stronger
association between having a restrictive spirometry pattern and low
physical activity in overweight (but not obese) subjects, compared to
those with normal weight. These results need to be interpreted with
caution. First, the differences in the effect estimates are not very large
and there is no evidence of statistical interaction. Second, despite
combining the two study-specific estimates, statistical power to analyse
associations within subgroups is still limited. Finally, obesity is known
to be a risk factor for restrictive spirometry pattern but it is also known
to be a cause and an effect of low physical activity levels. Assessing the
inter-relations between these components may require more repeated
valid measurements in larger cohorts.
4.2. Implications
Our study has important implications from the public health, clin-
ical and research perspectives. First, our results add ‘low physical ac-
tivity’ to the list of detrimental factors that are present in those with a
restrictive spirometry pattern. Physical inactivity puts these subjects at
risk of many chronic conditions and poor prognosis, and highlights the
necessity of detecting this spirometry pattern even in the absence of
respiratory symptoms. In the context of the increasing prevalence of
overweight and obesity, restrictive spirometry pattern may become a
major health concern in the future. Second, interventions encouraging
physical activity in individuals with a restrictive spirometry pattern
should be designed and tested. Having a restrictive spirometry pattern
is associated with poor quality of life and functional limitation [9,10],
therefore it is plausible that increasing one's physical activity could
improve quality of life and stabilise decreases in lung capacity. Finally,
our results suggest that physical inactivity may be behind the pre-
viously observed poor prognosis of restrictive spirometry pattern. Fur-
ther research could elucidate the mechanisms underlying these ob-
servations and specifically, the role of overweight and obesity.
4.3. Strengths and limitations
Physical activity data collected using questionnaires is known to be
subject to individual misclassification. However any imprecision in the
self-assessment of physical activity by questionnaires, and also in the
measurement of lung function, is likely to be non-differential, which
would attenuate the results. Unfortunately the designs of the two stu-
dies were not exactly identical, therefore the odds ratios were estimated
from subjects with slightly different age range and using a different set
of confounders. The fact that our analysis was based on data from the
second follow-up of the original studies could have resulted in a lower
number of participants with a restrictive spirometry pattern than in the
general population because of healthy-follow-up bias. This fact pre-
cludes the interpretation of the observed frequency of subjects with a
restrictive spirometry pattern as a prevalence estimate. However, a
potential healthy-follow up bias is unlikely to bias our results towards a
positive finding. Indeed, repeating the analysis using an inverse-
weighting method to correct for loss of follow-up in ECRHS did not
change the results. The use of study-specific lung reference equations
could be seen as a limitation since a different threshold was used to
define restrictive spirometry pattern in each study. However, the
methodology to derive the LLN and FVC %predicted was the same in
both studies and allows reference equations to approach better the lung
function distribution of each population. Further, the combined results
in the sensitivity analysis using GLI equations remained unchanged.
Finally, the analysis on the effect modification by BMI, sex and smoking
were underpowered despite our large sample.
The strengths of our study include the use of post-bronchodilator
lung function measurements to define restrictive spirometry pattern,
which are less prone to misclassification compared to pre-bronchodi-
lator measurements [7]. Second, we used two distinct methods for as-
sessing physical activity levels. Both methods yielded the same con-
clusion, thereby increasing the validity of our study.
Thirdly, the large number of participants and the detailed ques-
tionnaires and clinical visits allowed us to correct for most potential
confounders. Finally, our findings are likely to be generalisable given
that we could capitalise on data from two large population-based stu-
dies.
5. Conclusion
In two large European studies, adults with a restrictive spirometry
pattern had higher odds of low physical activity than those with normal
spirometry. These results were independent of BMI or the presence of
comorbidities and have important implications for the identification
and management of this understudied but prevalent condition.
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